09:01 AM EST, 11/11/2025 (MT Newswires) -- Sophia Genetics ( SOPH ) said Tuesday it entered into a partnership with biology firm Element Biosciences aiming to combine sequencing and AI analytics to streamline genomic workflows.

The collaboration will integrate Sophia Genetics' ( SOPH ) AI-powered analytics platform, Sophia DDM, with Element's AVITI24 5D multiomic and AVITI sequencing systems to deliver an end-to-end workflow for next-generation sequencing, the company said.

Shares of Sophia Genetics ( SOPH ) were 5.8% higher in premarket trading.